サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409847

テストステロン補充療法の世界市場レポート 2024年

Testosterone Replacement Therapy Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
テストステロン補充療法の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

テストステロン補充療法の市場規模は近年着実に成長しています。2023年の20億1,000万米ドルから2024年には20億7,000万米ドルへと、CAGR2.9％で成長します。この期間の成長は、性腺機能低下症の罹患率の増加、平均寿命の延長、ライフスタイルの進化、糖尿病やメタボリックシンドロームの流行、非侵襲的治療に対する患者の嗜好、男性不妊問題に対する関心の高まりなど、いくつかの要因に起因しています。

テストステロン補充療法の市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR2.2％で22億6,000万米ドルに成長します。予測期間における成長予測は、精密医療アプローチの採用、男性ウェルネス市場の拡大、支持的な規制措置、医療サービスの世界化、進化する健康とフィットネスの動向、男性の健康に対する社会的態度の変化など、さまざまな要因に関連しています。この期間に予想される主な動向には、治療のためのデリバリーシステムの革新、遠隔医療と遠隔モニタリングソリューションの広範な採用、カスタマイズされた治療計画の開発、健康に対する栄養とライフスタイルのアプローチへの注目、男性の健康とウェルネスのために調整された併用療法に関する研究の増加が含まれます。

テストステロン補充療法市場は、性腺機能低下症としても知られるテストステロン欠乏症の有病率の増加により成長が見込まれています。性腺機能低下症は、テストステロンレベルの低下を特徴とし、体内で十分な量のテストステロンを生成することができないです。テストステロン補充療法は、テストステロンレベルを生理的範囲内に上昇させ、性欲減退、勃起不全、抑うつ気分、貧血、筋肉減少などの症状を緩和するために使用されます。例えば、2022年にWestern Michigan Urological Associatesが発表した報告書によると、米国では約1,300万人の男性、つまり30歳以上の男性の4人に1人がテストステロン値の低下に苦しんでいることが明らかになった。このことは、テストステロン欠乏症の発生率の増加を強調し、テストステロン補充療法市場の拡大に寄与しています。

テストステロン補充療法市場の成長には、老人人口の増加がさらに拍車をかけています。老年人口は通常65歳以上の高齢者で構成され、テストステロン補充療法は高齢者のホルモンバランスを最適化し、幸福感を高め、機能的な健康をサポートするために採用されています。2022年10月現在、世界保健機関（WHO）は、2030年までに世界全体で6人に1人が60歳以上の高齢者となり、2050年までに21億人の高齢者が増加すると予測していると報告しています。高齢化社会への人口動態の変化は、テストステロン補充療法市場の成長を促進する重要な要因です。

2023年のテストステロン補充療法市場で最大の地域は北米でした。アジア太平洋は、テストステロン補充療法市場レポートにおいて予測期間中に最も急成長する地域となる見込みです。テストステロン補充療法市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 テストステロン補充療法市場の特徴

第3章 テストステロン補充療法市場の動向と戦略

第4章 テストステロン補充療法市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のテストステロン補充療法市場規模と成長

  • 世界のテストステロン補充療法市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のテストステロン補充療法の市場規模実績と成長、2018年から2023年
  • 世界のテストステロン補充療法市場規模と成長予測、2023年～2028年、2033年

第6章 テストステロン補充療法市場セグメンテーション

  • 世界のテストステロン補充療法市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • インプラント
  • ジェルまたはクリーム
  • パッチ
  • 頬粘膜接着剤
  • 非経口
  • その他の製品
  • 世界のテストステロン補充療法市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 性腺機能低下症
  • 自己免疫疾患
  • 遺伝性疾患
  • 性器手術
  • その他の適応症
  • 世界のテストステロン補充療法市場、有効成分タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • テストステロン
  • メチルテストステロン
  • ウンデカン酸テストステロン
  • エナント酸テストステロン
  • シピオン酸テストステロン
  • 世界のテストステロン補充療法市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • その他のエンドユーザー

第7章 テストステロン補充療法市場の地域および国分析

  • 世界のテストステロン補充療法市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のテストステロン補充療法市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋のテストステロン補充療法市場

第9章 中国のテストステロン補充療法市場

第10章 インドのテストステロン補充療法市場

第11章 日本のテストステロン補充療法市場

第12章 オーストラリアのテストステロン補充療法市場

第13章 インドネシアのテストステロン補充療法市場

第14章 韓国のテストステロン補充療法市場

第15章 西欧のテストステロン補充療法市場

第16章 英国のテストステロン補充療法市場

第17章 ドイツのテストステロン補充療法市場

第18章 フランスのテストステロン補充療法市場

第19章 イタリアのテストステロン補充療法市場

第20章 スペインのテストステロン補充療法市場

第21章 東欧のテストステロン補充療法市場

第22章 ロシアのテストステロン補充療法市場

第23章 北米のテストステロン補充療法市場

第24章 米国のテストステロン補充療法市場

第25章 カナダのテストステロン補充療法市場

第26章 南米のテストステロン補充療法市場

第27章 ブラジルのテストステロン補充療法市場

第28章 中東のテストステロン補充療法市場

第29章 アフリカのテストステロン補充療法市場

第30章 テストステロン補充療法市場の競合情勢と企業プロファイル

  • テストステロン補充療法市場の競合情勢
  • テストステロン補充療法市場の企業プロファイル
    • AbbVie Inc.
    • Acerus Pharmaceuticals Corporation
    • Antares Pharma Inc.
    • Bayer Aktiengesellschaft
    • BioTE Medical LLC

第31章 世界のテストステロン補充療法市場の競合ベンチマーキング

第32章 世界のテストステロン補充療法市場の競争ダッシュボード

第33章 テストステロン補充療法市場における主要な合併と買収

第34章 テストステロン補充療法市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11385

“Testosterone Replacement Therapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on testosterone replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for testosterone replacement therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The testosterone replacement therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: Oral; Implants; Gel Or Creams; Patches; Buccal Adhesive; Parenteral; Other Products
  • 2) By Indication: Hypogonadism; Autoimmune Conditions; Genetic Disorders; Sex Organ Surgeries; Other Indications
  • 3) By Active Ingredient Type: Testosterone; Methyl Testosterone; Testosterone Undecanoate; Testosterone Enanthate; Testosterone Cypionate
  • 4) By End User: Hospitals; Clinics; Other End-User
  • Companies Mentioned: AbbVie Inc.; Acerus Pharmaceuticals Corporation; Antares Pharma Inc.; Bayer Aktiengesellschaft; BioTE Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Testosterone replacement therapy is a hormonal treatment method utilized to address low testosterone (T) levels in males, commonly associated with aging or certain medical conditions.

The primary types of testosterone replacement therapy include oral formulations, implants, gels or creams, patches, buccal adhesives, parenteral administration, and other delivery methods. Oral administration involves intake through the mouth via tablets, capsules, syrups, or similar forms. Low testosterone indications encompass conditions such as hypogonadism, autoimmune disorders, genetic abnormalities, sex organ surgeries, and other related issues. Various active ingredients are employed in treating such conditions, including testosterone, methyl testosterone, testosterone undecanoate, testosterone enanthate, and testosterone cypionate. These therapies are administered by various end-users, including hospitals, clinics, and other healthcare facilities.

The testosterone replacement therapy market research report is one of a series of new reports from The Business Research Company that provides testosterone replacement therapy market statistics, including testosterone replacement therapy industry global market size, regional shares, competitors with a testosterone replacement therapy market share, detailed testosterone replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the testosterone replacement therapy industry. This testosterone replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The testosterone replacement therapy market size has grown steadily in recent years. It will grow from $2.01 billion in 2023 to $2.07 billion in 2024 at a compound annual growth rate (CAGR) of 2.9%. The observed growth in the historical period can be attributed to several factors, including the increasing incidence of hypogonadism, higher life expectancy rates, evolving lifestyles, the prevalence of diabetes and metabolic syndrome, preferences among patients for non-invasive therapies, and a rising concern regarding male infertility issues.

The testosterone replacement therapy market size is expected to see steady growth in the next few years. It will grow to $2.26 billion in 2028 at a compound annual growth rate (CAGR) of 2.2%. The projected growth in the forecast period can be linked to various factors, including the adoption of precision medicine approaches, the expanding male wellness market, supportive regulatory measures, the globalization of health services, evolving health and fitness trends, and shifting societal attitudes towards men's health. Key trends expected in this period encompass innovations in delivery systems for treatments, the widespread adoption of telemedicine and remote monitoring solutions, the development of customized treatment plans, a focus on nutritional and lifestyle approaches to health, and increased research on combination therapies tailored for male health and wellness.

The testosterone replacement therapy market is anticipated to experience growth due to the increasing prevalence of testosterone deficiency, also known as hypogonadism. Hypogonadism is characterized by low testosterone levels, where the body is unable to produce an adequate amount of testosterone. Testosterone replacement therapy is employed to elevate testosterone levels within the physiological range, addressing the effects of hypogonadism and alleviating symptoms such as reduced libido, erectile dysfunction, depressed mood, anemia, muscle loss, and more. For instance, a report by Western Michigan Urological Associates in 2022 highlighted that approximately 13 million men in the United States, equivalent to 1 in 4 males over the age of 30, suffer from low testosterone levels. This underscores the growing incidence of testosterone deficiency, contributing to the expansion of the testosterone replacement therapy market.

The growth of the testosterone replacement therapy market is further fueled by the rising geriatric population. The geriatric population comprises older adults, typically aged 65 or older, and testosterone replacement therapy is employed to optimize hormonal balance, enhance well-being, and support functional health in older individuals. As of October 2022, the World Health Organization reported that globally, 1 in 6 individuals would be 60 or older by 2030, with an expected increase to 2.1 billion elderly people by 2050. This demographic shift toward an aging population is a significant factor propelling the growth of the testosterone replacement therapy market.

Product innovation is a significant trend in the testosterone replacement therapy market, with companies focusing on the development of novel products to enhance their market position. One example of such innovation is the introduction of ACE-167 by Acesis BioMed. ACE-167 is a non-steroidal oral peptide therapy designed to treat low testosterone and hypogonadism. Unsuch as anabolic steroids, ACE-167 aims to stimulate the body's cells to naturally produce testosterone, offering an alternative with potentially fewer side effects and reduced abuse potential as compared to traditional testosterone treatments.

There is a growing emphasis on testosterone cypionate injections among major companies in the testosterone replacement therapy market. Testosterone cypionate is a synthetic form of the male sex hormone testosterone and is commonly prescribed as part of testosterone replacement therapy to address conditions associated with testosterone deficiency. In April 2023, Xiromed LLC launched Testosterone Cypionate Injection (USP), providing a new option for males with low testosterone or related conditions such as erectile dysfunction or hypogonadism. This injectable form of testosterone is recognized for its effectiveness in restoring testosterone levels to a healthy range, making it a valuable solution for hormone replacement therapy, especially for individuals experiencing symptoms of testosterone deficiency.

The acquisition of Clarus Therapeutics Inc. by Tolmar Pharmaceuticals Inc. in October 2022 is a strategic move to enhance Tolmar's portfolio in urology and men's health. By acquiring Clarus Therapeutics, Tolmar gains access to JATENZO, a testosterone replacement therapy developed by Clarus Therapeutics. This acquisition allows Tolmar Pharmaceuticals to expand its offerings in the field of testosterone therapy, further solidifying its presence and capabilities in urology and men's health. The specific terms and financial details of the acquisition were not disclosed, but such strategic acquisitions are common in the pharmaceutical industry to strengthen product portfolios and market positions.

Major companies operating in the testosterone replacement therapy market report are AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc., Bayer Aktiengesellschaft, BioTE Medical LLC, Clarus Therapeutics Inc., Eli Lilly and Company, Endo International plc, Pfizer Inc., Teva Pharmaceutical Industries Limited, Acrux Limited, Actiza Pharmaceutical Inc., Aytu BioPharma Inc., Cipla Limited, Sun Pharmaceutical Industries Limited, The Simple Pharma Company UK Limited, Ferring Pharmaceuticals Holdings S.A., Mylan N.V., Bausch Health Companies Inc., Allergan plc, Addex Therapeutics Ltd., Astraea Therapeutics LLC, Cerecor Inc., Embera NeuroTherapeutics Inc, Hager Biosciences LLC, Heptares Therapeutics Limited, Omeros Corporation, RTI International, Sandoz International GmbH, Perrigo Company plc, Besins Healthcare .

North America was the largest region in the testosterone replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the testosterone replacement therapy market report during the forecast period. The regions covered in the testosterone replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the testosterone replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The testosterone replacement therapy market includes revenues earned by entities by providing hormone testing, semen analysis, pituitary imaging, genetic studies, and testicular biopsy to treat low testosterone deficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Testosterone Replacement Therapy Market Characteristics

3. Testosterone Replacement Therapy Market Trends And Strategies

4. Testosterone Replacement Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Testosterone Replacement Therapy Market Size and Growth

  • 5.1. Global Testosterone Replacement Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Testosterone Replacement Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Testosterone Replacement Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Testosterone Replacement Therapy Market Segmentation

  • 6.1. Global Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Implants
  • Gel Or Creams
  • Patches
  • Buccal Adhesive
  • Parenteral
  • Other Products
  • 6.2. Global Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hypogonadism
  • Autoimmune Conditions
  • Genetic Disorders
  • Sex Organ Surgeries
  • Other Indications
  • 6.3. Global Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Testosterone
  • Methyl Testosterone
  • Testosterone Undecanoate
  • Testosterone Enanthate
  • Testosterone Cypionate
  • 6.4. Global Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Other End-User

7. Testosterone Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Testosterone Replacement Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Testosterone Replacement Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Testosterone Replacement Therapy Market

  • 8.1. Asia-Pacific Testosterone Replacement Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Testosterone Replacement Therapy Market

  • 9.1. China Testosterone Replacement Therapy Market Overview
  • 9.2. China Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Testosterone Replacement Therapy Market

  • 10.1. India Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Testosterone Replacement Therapy Market

  • 11.1. Japan Testosterone Replacement Therapy Market Overview
  • 11.2. Japan Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Testosterone Replacement Therapy Market

  • 12.1. Australia Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Testosterone Replacement Therapy Market

  • 13.1. Indonesia Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Testosterone Replacement Therapy Market

  • 14.1. South Korea Testosterone Replacement Therapy Market Overview
  • 14.2. South Korea Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Testosterone Replacement Therapy Market

  • 15.1. Western Europe Testosterone Replacement Therapy Market Overview
  • 15.2. Western Europe Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Testosterone Replacement Therapy Market

  • 16.1. UK Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Testosterone Replacement Therapy Market

  • 17.1. Germany Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Testosterone Replacement Therapy Market

  • 18.1. France Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Testosterone Replacement Therapy Market

  • 19.1. Italy Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Testosterone Replacement Therapy Market

  • 20.1. Spain Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Testosterone Replacement Therapy Market

  • 21.1. Eastern Europe Testosterone Replacement Therapy Market Overview
  • 21.2. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Testosterone Replacement Therapy Market

  • 22.1. Russia Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Testosterone Replacement Therapy Market

  • 23.1. North America Testosterone Replacement Therapy Market Overview
  • 23.2. North America Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Testosterone Replacement Therapy Market

  • 24.1. USA Testosterone Replacement Therapy Market Overview
  • 24.2. USA Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Testosterone Replacement Therapy Market

  • 25.1. Canada Testosterone Replacement Therapy Market Overview
  • 25.2. Canada Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Testosterone Replacement Therapy Market

  • 26.1. South America Testosterone Replacement Therapy Market Overview
  • 26.2. South America Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Testosterone Replacement Therapy Market

  • 27.1. Brazil Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Testosterone Replacement Therapy Market

  • 28.1. Middle East Testosterone Replacement Therapy Market Overview
  • 28.2. Middle East Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Testosterone Replacement Therapy Market

  • 29.1. Africa Testosterone Replacement Therapy Market Overview
  • 29.2. Africa Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Testosterone Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Testosterone Replacement Therapy Market Competitive Landscape
  • 30.2. Testosterone Replacement Therapy Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Acerus Pharmaceuticals Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Antares Pharma Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer Aktiengesellschaft
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. BioTE Medical LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Testosterone Replacement Therapy Market Competitive Benchmarking

32. Global Testosterone Replacement Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Testosterone Replacement Therapy Market

34. Testosterone Replacement Therapy Market Future Outlook and Potential Analysis

  • 34.1 Testosterone Replacement Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Testosterone Replacement Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Testosterone Replacement Therapy Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer